第一临床学院-李肖导师介绍
李肖
教授
博士生导师
男
第一临床学院
影像医学与核医学
肝硬化门静脉高压,肿瘤介入消融,粒子治疗临床研究,TIPS临床研究
simonlixiao@263.net
博士招生专业
1
影像医学与核医学
2024
1
学术型博士
不区分方向
2
影像医学与核医学
2024
1
专业学位博士
不区分方向
硕士招生专业
1
影像医学与核医学
2023
1
学术型硕士
不区分方向
李肖，国家癌症中心/中国医学科学院＆北京协和医学院•肿瘤医院•介入治疗科主任兼党支部书记，北京协和医学院、四川大学和中国医科大学博士研究生导师、博士后合作导师；曾任四川大学华西医院介入诊疗中心主任，兼具综合医院和肿瘤专科医院工作与学术背景，擅长门静脉高压及肿瘤相关疾病的微创介入诊疗，专业特长包括以经颈静脉肝内门体分流术（TIPS）为代表的血管性介入治疗、以肿瘤消融和粒子植入为代表的非血管性介入治疗；曾荣登2017-2018年度《中国名医百强榜》门脉高压介入治疗榜首，获得首届人民健康网“国之名医-优秀风范”称号，获选为首批国家卫健委“全国卫生健康技术应用项目-TIPS推广传承人”，获得中华医学科技奖一等奖、四川省科技进步一等奖；担任《中国介入影像与治疗学》杂志主编、《中国临床医师杂志》副主编；主持国家重点研发计划、国家自然科学基金6项；以第一或通讯作者发表SCI论文70余篇；培养博士后、博士和硕士60余人。
展开更多
科研项目
1. 经颈静脉肝内门体静脉分流术关键穿刺套件研发，北京市科技计划
2. 金纳米颗粒涂层支架光热效应预防大鼠气道支架植入后支架相关狭窄的实验研究，国家自然科学基金面上项目
3. 糖代谢异常在肝癌介入中的作用及治疗研究，国家自然科学基金面上项目
4. 基于增强现实导航的肺癌介入诊治一体化关键技术研究，国家重点研发计划
5. 经皮脾肾分流术治疗肝硬化门脉高压症的实验研究，国家自然科学基金面上项目
6. 门静脉栓塞选择性诱导肝叶增生的实验研究，国家自然科学基金面上项目
7. 动脉栓塞联合非细胞毒性药物治疗大鼠肝癌的实验研究，国家自然科学基金面上项目
8. AuNPs涂层支架的放疗增敏效应及在食管癌中的疗效探索，山西省基础研究计划项目面上项目
9. 基于多源跨尺度信息动态融合的TIPS治疗门静脉高压智能规划与精准导航研究，国家自然科学基金重点项目
展开更多
研究成果
1. Yan Fu, Chu Hui Zeng, Chao An, Yue Liu, Ji Hoon Shin, Xiao Li. How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles. Cancers (Basel). 2023 Feb 19;15(4):1324.
2. Tianhao Cong, Yingen Luo, Yu Li, Chao Yang, Hongcai Yang, Yujie L, Jingui Li, Xiao Li. Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma. Front Genet. 2022 Oct 5;13:1000997.
3. He Zhao, Jiaywei Tsauo, Xiaowu Zhang, Huaiyuan Ma, Ningna Weng, Zhengqiang Yang, Xiao Li. Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective cohort study. Chin Med J (Engl). 2022 Sep 5;135(17):2043-2048.
4. Chao Yang, Yin-Gen Luo, Hong-Cai Yang, Zhi-Hang Yao, Xiao L. Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study. J Hepatocell Carcinoma. 2022 Jul 21;9:621-631.
5. Yujing Xin, Fei Cao, Hongcai Yang, Xinyuan Zhang, Yi Chen, Xiaojing Cao, Xiang Zhou, Xiao Li, Jinxue Zhou. Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Front Immunol. 2022 Aug 5;13:929141.
6. Xiaowu Zhang, Yingen Luo, Jiaywei Tsauo, He Zhao, Tao Gong, Jingui Li, Yawei Li, Huiying Zeng, Wei Sun, Xiao Li. Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial. Eur Radiol. 2022 Oct;32(10):6812-6819.
7. Yuze Li,1,† Ziming Xu,1,† Chao An,2 Huijun Chen,1,* and Xiao Li3,* Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial Chemoembolization. J Pers Med. 2022 Feb; 12(2): 248.
8. Xiaowu Zhang, Jiaywei Tsauo, Jun Tie, Hui Xue, Jian-Bo Zhao, Jian-Jun Li, Zhu-Ting Fang, Wu-Hua Guo, Xiao Li. Emergent Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Gastric Variceal Bleeding in Patients with Hepatocellular Carcinoma. J Vasc Interv Radiol. 2022 Jun;33(6):702-706.
9. He Zhao, Xiaowu Zhang, Jiaywei Tsauo, Jingui Li, Tao Gong, Mingchen San, Xiao L. Comparison of the in vitro clot-capturing efficiencies of commercially available retrievable inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2022 Mar;10(2):463-468.e2.
10. He Zhao, Yan Fu, Jiaywei Tsauo, Xiaowu Zhang, Yanqing Zhao, Tao Gong, Jingui Li, Xiao Li. Silver nanoparticle-coated self-expandable metallic stent suppresses tissue hyperplasia in a rat esophageal model. Surg Endosc. 2022 Jan;36(1):66-74.
11. Yan Fu, Tao Gong, Jiaywei Tsauo, Mingchen Sang, He Zhao, Xiaowu Zhang, Jingui Li, Xiao Li. Nintedanib, a multitarget tyrosine kinase inhibitor, suppresses postoperative peritoneal adhesion formation in a rat model. Surgery. 2021 Sep;170(3):806-812.
12. Jiaywei Tsauo, Jun Tie, Hui Xue, Jian-Bo Zhao, Jian-Jun Li, Zhu-Ting Fang, Wu-Hua Guo, Xiao Li. Transjugular Intrahepatic Portosystemic Shunt Creation for the Prevention of Gastric Variceal Rebleeding in Patients with Hepatocellular Carcinoma: A Multicenter Retrospective Study. J Vasc Interv Radiol. 2021 Jul;32(7):963-969.
13. He Zhao, Jiaywei Tsauo, Xiao-Wu Zhang, Huai-Yuan Ma, Ning-Na Weng, Gong-Shun Tang, Xiao Li. Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake. World J Gastroenterol. 2020;26(10):1088-1097.
14. Yanqing Zhao, Xiaowu Zhang, He Zhao, Tao Gong, Jingui Li, Jiaywei Tsauo, Xiao Li. Systemic Therapy Plus Thermal Ablation Versus Systemic Therapy Alone for Oligometastatic Liver Metastases from Non-small Cell Lung Cancer. Cardiovasc Intervent Radiol. 2020;43(9):1285-1293.
15. Tsauo J, Zhao H, Zhang X, Ma H, Jiang M, Weng N, Li X. Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome. Eur Radiol. 2019;29(6):3273-3280.
16. Tsauo J1, Zhao H1, Zhang X1, Ma H2, Jiang M2, Weng N2, Li X3. Effect of Transjugular Intrahepatic Portosystemic Shunt Creation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: A Prospective Study. J Vasc Interv Radiol. 2019;30(2):170-177.
17. Yu J, Wang X, Jiang M, Ma H, Zhou Z, Yang L, Li X. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study. Eur Radiol. 2019;29(2):699-706.
18. Qiu B, Zhang X, Tsauo J, Zhao H, Gong T, Li J, Li X. Transcatheter arterial infusion for pancreatic cancer: a 10-year National Cancer Center experience in 115 patients and literature review. Abdom Radiol (NY). 2019;44(8):2801-2808.
19. Li X, Tsauo J, Geng C, Zhao H, Lei X, Li X. Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1 α Pathway in Hepatocellular Carcinoma: A Novel Antitumor Mechanism. Am J Chin Med. 2018;46(8):1915-1931.
20. Zhao H, Tsauo J, Zhang X, Li X. Regarding "The optimal procedure of modified Rex shunt for the treatment of extrahepatic portal hypertension in children". J Vasc Surg Venous Lymphat Disord. 2018;6(3):421-422.
21. Huang X, Tsauo J, Zhao H, Li X. Re: Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures. J Vasc Interv Radiol. 2018;29(4):586.
22. Zhao H, Tsauo J, Zhang X, Ma H, Weng N, Wang L, Li X. Pulmonary transit time derived from pulmonary angiography for the diagnosis of hepatopulmonary syndrome. Liver Int. 2018;38(11):1974-1981.
23. Tao Z, Yan C, Zhao H, Tsauo J, Zhang X, Qiu B, Zhao Y, Li X. Comparison of endoscopic ultrasonography and magnifying endoscopy for assessment of the invasion depth of shallow gastrointestinal neoplasms: a systematic review and meta-analysis. Surg Endosc. 2017;31(12):4923-4933.
24. Luo X, Wang X, Zhao Y, Ma H, Ye L, Yang L, Tsauo J, Jiang M, Li X. Real-Time 3D CT Image Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation Using Preoperative CT: A Prospective Feasibility Study of 20 Patients. AJR Am J Roentgenol. 2017 Jan;208(1):W11-W16.
25. Deng P, Zhou B, Li X. Risk factors contributing to early infection following transjugular intrahepatic portosystemic shunt in perioperative period. Ann Hepatol. 2016 Sep-Oct;15(5):752-6.
26. Zhang X, Li X. Successful Embolization of a Huge Hepatic Artery Pseudoaneurysm after Blunt Abdominal Trauma. J Pediatr. 2016;168:252-252.e1.
27. Tsauo J, Li X. Viatorr TIPS Endoprosthesis Versus Generic Expanded Polytetrafluoroethylene-Covered Stent-Grafts. AJR Am J Roentgenol. 2015;205(4): W463.
28. Zhao H, Tsauo J, Wang X, Li X. Accurate measurement of the normality values of macroaggregated albumin lung perfusion scan in hepatopulmonary syndrome. Ann Nucl Med. 2015t;29(8):754-5.
29. Tsauo J, Weng N, Ma H, Jiang M, Zhao H, Li X. Role of Transjugular Intrahepatic Portosystemic Shunts in the Management of Hepatopulmonary Syndrome: A Systemic Literature Review. J Vasc Interv Radiol. 2015 Sep;26(9):1266-71.
30. Luo X, Ye L, Zhou X, Tsauo J, Zhou B, Zhang H, Zhang X, Li X. C-Arm Cone-Beam Volume CT in Transjugular Intrahepatic Portosystemic Shunt: Initial Clinical Experience. Cardiovasc Intervent Radiol. 2015;38(6):1627-31.
31. Tsauo J, Li X. Portal vein aneurysm associated with Budd-Chiari syndrome treated with transjugular intrahepatic portosystemic shunt: a case report. World J Gastroenterol. 2015;21(9):2858-61.
32. Wang Z, Zhao H, Wang X, Zhang H, Jiang M, Tsauo J, Luo X, Yang L, Li X. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis. Abdom Imaging. 2015;40(6):1813-20.
33. Jiang M, Wang Z, Tsauo J, Li X. Basal ganglia hyperintensity may be a marker of hepatic encephalopathy secondary to portosystemic shunting. Clin Res Hepatol Gastroenterol. 2015;39(1):e5-6.
34. Zhou Y, Tsauo J, Li Y, Li X. Selective Embolization of Systemic Collaterals for the Treatment of Recurrent Hemoptysis Secondary to the Unilateral Absence of a Pulmonary Artery in a Child. Cardiovasc Intervent Radiol. 2015;38(5):1312-5.
35. Tsauo J, Luo X, Ye L, Li X. Three-dimensional path planning software-assisted transjugular intrahepatic portosystemic shunt: a technical modification. Cardiovasc Intervent Radiol. 2015;38(3):742-6.
36. Zhao H, Tsauo J, Ma HY, Li X. The role of macroaggregated albumin lung perfusion scan in hepatopulmonary syndrome: are we ready to draw conclusions? Liver Int. 2015;35(7):1918-9.
37. Chen 1, Wang W, Tam MD, Quintini C, Fung JJ, Li X. Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes. Hepatol Int. 2015;9(3):391-8.
38. Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus EndoscopicBand Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. Radiology. 2015; 276(1):286-93.
39. Luo X, Nie L, Zhou B, Yao D, Ma H, Jiang M, Zhang H, Li X. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma. Gastroenterol Res Pract. 2014;2014:659726. doi: 10.1155/2014/659726.
40. Wang Z, Zhang H, Zhao H, Wang X, Tsauo J, Luo X, Li X. Repeated transcatheter arterial chemoembolization is safe for hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Diagn Interv Radiol. 2014;20(6):487-91.
41. Jiang M, Wang Z, Tsauo J, Li X. Basal ganglia hyperintensity may be a marker of hepatic encephalopathy secondary to portosystemic shunting. Clin Res Hepatol Gastroenterol. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):e5-6.
42. Zhou Y, Tsauo J, Li Y, Li X. Selective Embolization of Systemic Collaterals for the Treatment of Recurrent Hemoptysis Secondary to the Unilateral Absence of a Pulmonary Artery in a Child. Cardiovasc Intervent Radiol. 2015 Oct;38(5):1312-5.
43. Tsauo J, Yu Y, Luo X, Wang Z, Liu L, Li X. Direct intrahepatic portocaval shunt creation via the inter-strut space of the inferior vena cava stent. Clin Radiol. 2014 Sep;69(9):896-9.
44. Yu Y, Zhang C, Liu L, Li X. Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas. Exp Ther Med. 2013;5:761-766.
45. Tsauo J, Yang D, Ma H, Li X. Traumatic Inferior Gluteal Artery Pseudoaneurysm with Compressive Neuropathy Managed with Endovascular Embolization and Surgery. Cardiovasc Intervent Radiol. 2014;37(1):275-7.
46. Tsauo J, Liu L, Li X. Hepatobiliary and pancreatic: transient hepatic ischemia caused by acute portal vein thrombosis. J Gastroenterol Hepatol. 2013;28(9):1433.
47. Tsauo J, Liu L, Tang C, Li X. Education and Imaging. Hepatobiliary and pancreatic: spontaneous intrahepatic portosystemic shunt associated with cirrhosis. J Gastroenterol Hepatol. 2013;28(6):904.
48. Tsauo J, Liu L, Li X. Hepatobiliary and pancreatic: transient hepatic ischemia caused by acute portal vein thrombosis. J Gastroenterol Hepatol. 2013;28:1433.
49. Tsauo J, Li X, Li H, Wei B, Luo X, Zhang C, Tang C. Transjugular insertion of bare-metal biliary stent for the treatment of distal malignant obstructive jaundice complicated by coagulopathy. Cardiovasc Intervent Radiol. 2013;36:521-525.
50. Luo XF, Nie L, Wang Z, Tsauo J, Liu LJ, Yu Y, Zhou B, Li X. Stent-grafts for the treatment of TIPS dysfunction: fluency stent vs Wall graft stent. World J Gastroenterol. 2013;19:5000-5005.
51. Luo X, Nie L, Wang Z, Tsauo J, Tang C, Li X. Transjugular Endovascular Recanalization of Splenic Vein in Patients with Regional Portal Hypertension Complicated by Gastrointestinal Bleeding. Cardiovasc Intervent Radiol. 2014 Feb;37(1):108-13.
52. Luo X, Nie L, Tsauo J, Wang Z, Tang C, Li X. Parallel shunt for the treatment of transjugular intrahepatic portosystemic shunt dysfunction. Korean J Radiol 2013;14:423-429.
53. Chen S, Li X, Wei B, Tong H, Zhang MG, Huang ZY, Cao JW. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology. 2013;268:900-906.
54. Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep. 2012;5:1295-1298.
55. Wang Z, Yu Y, Yang W, Chen B, Li X. Does Helicobacter pylori eradication really reduce the risk of gastric cancer at the population level? Gut. 2013 Jun;62(6):950.
56. Nie L, Luo XF, Li X. Gastrointestinal bleeding caused by extrahepatic arterioportal fistula associated with portal vein thrombosis. World J Gastroenterol. 2012;18:6501-6503.
57. Liu L, Yu Y, Zhang C, Luo X, Tsauo J, Tang C, Li X. Education and Imaging. Hepatobiliary and pancreatic: hepatocellular carcinoma supplied by portal blood after repeated transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2012;27:1408.
58. Liu L, Yu Y, Jin X, Wang Z, Li X. Management of superior mesenteric arteriovenous fistula after small bowel resection 20 years previously: endovascular treatment. Can J Gastroenterol. 2012;26:864-865.
59. Chen B, Tang CW, Zhang CL, Cao JW, Wei B, Li X. Melena-associated regional portal hypertension caused by splenic arteriovenous fistula. World J Gastroenterol. 2012;18:1996-1998.
60. Tsauo J, Luo X, Ye L, Li X. Three-Dimensional Path Planning Software-Assisted Transjugular Intrahepatic Portosystemic Shunt: A Technical Modification. Cardiovasc Intervent Radiol. 2014 Jun 17. [Epub ahead of print] PMID: 24934737.
61. Yao D, Kunam VK, Li X.A review of the clinical diagnosis and therapy of cholangiocarcinoma. J Int Med Res. 2014;42(1):3-16.
62. Yao D, Luo X, Zhou B, Li X. Ileal conduit stomalvariceal bleeding managed by endovascular embolization. World J Gastroenterol. 2013; 19(44): 8156–8159.
63. Luo X, Nie L, Wang Z, Tsauo J, Tang C, Li X. Transjugular endovascular recanalization of splenic vein in patients with regional portal hypertension complicated by gastrointestinal bleeding. Cardiovasc Intervent Radiol. 2014 Feb;37(1):108-13.
64. Tsauo J, Yang D, Ma H, Li X. Traumatic inferior gluteal artery pseudoaneurysm with compressive neuropathy managed with endovascular embolization and surgery. Cardiovasc Intervent Radiol. 2014 Feb;37(1):275-7.
65. Li X, Li F, Wei B, Li B, Tang CW. Small-for-size syndrome after living donor liver transplantation: successful treatment with a transjugular intrahepatic portosystemic shunt. Liver Transpl. 2012;18:1118-1120.
66. Liu L, Yu Y, Zhang C, Luo X, Tsauo J, Tang C, Li X. Education and Imaging. Hepatobiliary and pancreatic: hepatocellular carcinoma supplied by portal blood after repeated transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2012;27(8):1408.
67. Li X, Tang CW. An obscure mass in the head of the pancreas of an adolescent. Gut. 2011;60(8):1086, 1138.
68. Li X, Li HC, Tang CW. Endovascular embolization for gastrointestinal bleeding caused by splenic arteriovenous fistula. Chin Med J (Engl) 2010;123:2616-2618.
69. Li X, Zhou X, Guan Y, Wang YX, Scutt D, Gong QY. N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: radiological and histopathological studies. Cardiovasc Intervent Radiol. 2006;29(3):420-8.
70. Li X, Wang YX, Zhou X, Guan Y, Tang C. Catheterization of the hepatic artery via the left common carotid artery in rats. Cardiovasc Intervent Radiol. 2006;29(6):1073-6.
71. Li X, Zhou XP, Guan YS, Wang YX. Magnetic resonance imaging of hepatocellular carcinoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):427-32.
展开更多
学校介绍
中国医科大学是中国共产党最早创建的院校，是唯一以学校名义走完红军两万五千里长征全程并在长征中继续办学的院校，是我国最早进行西医学学院式教育的医学高校之一。其前身为中国工农红军军医学校和中国工农红军卫生学校，1931年11月创建于江西瑞金。1940年9月在延安，经毛泽东同志提议，中共中央批准，学校更名为中国医科大学。1948年11月，在沈阳合并了原国立沈阳医学院（前身为满州医科大学，1911年由日本国南满铁道株式会社建立）和原私立辽宁医学院（前身为盛京医科大学，1883年由英国苏格兰教会建立）。中国医科大学是卫生部原部属高等医学院校，2000年改为省部共建学校。
中国医科大学建校至今，共培养了8万多名高级医学专门人才，毕业生遍布全国各地及世界许多国家和地区，培养和造就了一大批国家卫生管理的著名领导干部和医学界的著名专家学者。据不完全统计，担任副部级以上职务百余位，卫生部正、副部长9位，将军40多位，中国科学院、中国工程院院士13位。
学校设有28个院、系、部。在医学、教育学、理学、工学、哲学和管理学等6学科门类拥有学位授予权；在基础医学、临床医学、生物学、口腔医学、公共卫生与预防医学、护理学等6个学科具有一级学科博士学位授予权，设有博士学位授权学科(专业) 56个，硕士学位授权学科(专业) 67个；国家重点学科5个（内科学(呼吸系病)、皮肤病与性病学、外科学(普外)、内科学（内分泌与代谢病）、劳动卫生与环境卫生学），国家重点（培育）学科1个（影像医学与核医学）；卫生部国家临床重点专科建设项目30个；“辽宁省提升高等学校核心竞争力特色学科建设工程”立项学科29个；博士后流动站6个；本科专业16个。国家级教学项目有五年制临床医学专业人才培养模式改革试点项目1项，临床医学拔尖人才培养改革试点项目1项，人才培养模式创新实验区1个，特色专业建设点5个，精品课程11门，教学团队2个，双语教学示范课程1门，实验教学示范中心2个，精品教材2本；省级教学项目有示范性专业7个，品牌专业1个，本科教学综合改革试点专业1个，重点支持专业1个，工程类人才培养模式改革试点专业1个，精品课程40门，精品视频公开课5门，精品资源共享课13门，教学团队10个，双语教学示范课程2门，实验教学示范中心6个，实践教育基地（校外）2个，紧缺人才培养基地1个，精品教材8本。有国家研究基地2个，教育部重点实验室1个，科技部省部共建国家重点实验室培育基地1个，省部共建教育部重点实验室1个，卫生部重点实验室4个，国家中医药管理局中医药科研实验室（三级）3个，辽宁省高校重大科技平台2个，辽宁省重点实验室14个，辽宁省高校重点实验室15个，辽宁省工程技术研究中心1个，辽宁省研究中心3个；有辽宁省医疗中心54个。学校附属3所综合性医院和1所专科性医院，开放床位8304张，牙科综合治疗椅185张。
学校在职教职工13710人，各类专业技术人员占职工总数的83.7％，其中中国工程院院士1人，教育部长江学者特聘教授1人、讲座教授1人，在职的国务院特殊津贴获得者59人，辽宁省领军人才2人，辽宁特聘教授9人，辽宁省优秀专家11人。教授级633人，副教授级905人，研究生指导教师994人，其中博士生指导教师472人。在校各类学生57799人，全日制在校生16029人，其中博士生1163人，硕士生3951（含七年制）人，普通本专科生9480人，外国留学生和港澳台学生439人，附设卫生学校学生996人。
教师中在中华医学会等全国性学术团体中担任常委（常务理事）以上者65人，其中担任主任委员者11人（含候任主任委员和名誉主任委员），担任副主任委员者18人；有国务院学位委员会学科评议组成员2人，高等学校国家级教学名师1人，高等学校省级教学名师12人，新世纪百千万人才工程国家级4人，国家杰出青年科学基金项目获得者1人，教育部“长江学者和创新团队发展计划”团队2个，有突出贡献专家国家级3人、卫生部11人次、省级7人次，辽宁省高等学校学科拔尖人才2人，辽宁省高等学校攀登学者12人，辽宁省普通高校专业带头人5人，辽宁省高校中青年学科带头人4人，省普通高等学校优秀青年骨干教师64人，辽宁省“百千万人才工程”百人层次105人、千人层次88人。
学校总占地面积180万平方米，建筑面积为62.9万平方米。图书馆是卫生部全国医学文献资源共享网络东北地区中心馆，卫生部医药卫生科技项目查新咨询单位；馆藏纸质书刊112万册，电子资源计20TB；订购中外文全文书刊数据库31种，日文医学文献收藏尤其丰富，为全国日文医学文献中心馆。实验动物部是辽宁省实验动物质量检测中心和辽宁省转基因动物研究重点实验室的依托单位。主办学术期刊16种。
学校与美国、英国、法国、日本、俄罗斯、韩国、加拿大、澳大利亚、意大利、丹麦以及澳门和台湾等国家、地区的82所大学、科研机构建立了良好的交流关系，与世界银行(WBG)、美国中华医学基金会(CMB)、日本国际协力事业团(JICA)等机构开展了卓有成效的合作。有300多名国际知名专家学者受聘为学校荣誉职称，先后派出教师5133人次到国外研修和考察，近年来开展了56项重要国际合作项目，34个CMB项目。
展开更多